Medical management of functioning pituitary adenoma: an update.

about

Prescription patterns of long-acting somatostatin analogues Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.

P2860

Q33694027-A368D0D0-1491-4544-BA63-CA42228D687B Q47193600-277113BD-EB32-4161-BEE6-CFD21B1A5488

P2860

Medical management of functioning pituitary adenoma: an update.

Item

http://www.wikidata.org/entity/Q35943493

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Medical management of functioning pituitary adenoma: an update.

@ast

Medical management of functioning pituitary adenoma: an update.

@en

type

Item

label

Medical management of functioning pituitary adenoma: an update.

@ast

Medical management of functioning pituitary adenoma: an update.

@en

prefLabel

Medical management of functioning pituitary adenoma: an update.

@ast

Medical management of functioning pituitary adenoma: an update.

@en

P1476

Medical management of functioning pituitary adenoma: an update.

@en

P2093

Yutaka Oki

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Dopamine agonists and the risk of cardiac-valve regurgitation

Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.

Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.

Incidence and late prognosis of cushing's syndrome: a population-based study.

Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.

Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients.

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.

P304

958-965

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2176/NMC.RA.2014-0239

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2014-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25446388

http://www.w3.org/2001/XMLSchema#string

P921

P932

4533360

http://www.w3.org/2001/XMLSchema#string

Medical management of functioning pituitary adenoma: an update.

about

P2860

P2860

Medical management of functioning pituitary adenoma: an update.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932